NBC’s ‘Brilliant Minds’ Ratings Plummet Leading to Cancellation After Two Seasons

LOS ANGELES — NBC has canceled the medical drama “Brilliant Minds” after two seasons, citing steep year-over-year viewership declines that made the Zachary Quinto-led series the network’s lowest-rated drama on linear television. The decision, announced Friday, marks one of the first cancellations ahead of the network’s 2026-27 upfront presentations and reflects broader challenges in broadcast scripted programming amid shifting audience habits.

“Brilliant Minds,” inspired by the life and work of neurologist Oliver Sacks, follows Dr. Oliver Wolf, an eccentric but brilliant neurologist with a unique perspective on treating complex psychological and neurological cases. The show earned strong critical praise, holding an 88% Rotten Tomatoes score, yet struggled to translate acclaim into consistent viewership.

Season 2 averaged just above 3 million viewers with seven days of linear viewing — the smallest total of any NBC drama this season. That figure represented double-digit declines from Season 1, which itself had modest numbers for a post-“The Voice” Monday night slot. In key advertiser demographics, particularly adults 18-49, the series frequently dipped below 0.2 ratings, with some episodes hitting historic lows around 0.10-0.12.

An early sign of trouble came in February 2026 when NBC pulled the series from its regular schedule to accommodate expanded two-hour episodes of “The Voice” following the Winter Olympics. At that point, only 14 of a planned 22 episodes had aired. The remaining six episodes will now burn off during summer starting May 27.

From Promising Start to Steep Decline

When “Brilliant Minds” premiered in September 2024, it showed early promise. The pilot drew solid initial numbers, benefiting from the powerhouse lead-in of “The Voice.” Season 1 averaged around 2.97 million viewers and a 0.23 rating in the 18-49 demo, ranking it among new dramas but still modest by traditional broadcast standards.

Expectations were higher for Season 2 with returning cast familiarity and critical momentum. Yet audiences failed to return in force. Live ratings eroded steadily through fall 2025 and into early 2026. Episodes in January and February frequently drew under 1.5 million same-day viewers, with total audience (including DVR) barely cracking 3 million in many cases.

Industry analysts point to multiple factors. Broadcast dramas face intense competition from streaming platforms, where shorter attention spans and on-demand viewing dominate. “Brilliant Minds” reportedly failed to crack Peacock’s top 10 charts consistently, limiting the streaming boost that often saves marginal network shows.

The series also competed internally against NBC’s stronger procedural franchises like “Chicago Med,” “Law & Order” and “The Hunting Party.” Monday nights, while anchored by “The Voice,” proved challenging for serialized medical storytelling that required viewer commitment week after week.

Critical Acclaim vs. Commercial Reality

Despite the ratings woes, “Brilliant Minds” stood out creatively. Reviewers praised Quinto’s nuanced performance as the neurodivergent Dr. Wolf, the show’s thoughtful exploration of mental health and neurological conditions, and strong supporting work from cast members including Tamberla Perry and Ashleigh LaThrop. Audience scores on Rotten Tomatoes hovered around 81%, indicating passionate fans who connected with its empathetic approach to patient stories.

Showrunners and producers aimed for a blend of medical procedural and character-driven drama, drawing from real neurological cases. Episodes tackled everything from phantom limb syndrome to rare cognitive disorders, often weaving in the personal struggles of Wolf and his team of interns. Many viewers and critics lauded the series for humanizing complex conditions without sensationalism.

Yet in today’s television economy, even well-reviewed shows with solid but unspectacular numbers face cancellation. NBC, like other broadcast networks, prioritizes live-linear performance for ad revenue while hoping for streaming longevity. “Brilliant Minds” delivered neither at a level sufficient for renewal.

Broader Context for NBC’s Scripted Slate

The cancellation arrives as NBC evaluates its lineup ahead of upfronts. Alongside “Brilliant Minds,” the network axed freshman comedy “Stumble,” which averaged just 2.24 million viewers. Several other series, including “Law & Order” and “The Hunting Party,” remain on the bubble.

The moves signal a strategic shift. NBC has ordered multiple drama pilots for the coming season, seeking fresh voices and potentially higher-concept projects to combat cord-cutting and audience fragmentation. Medical dramas remain a staple, but networks increasingly favor established IP or star-driven vehicles with proven track records.

For “Brilliant Minds,” the end comes after 27 total episodes across two seasons. Producers have not commented publicly on future plans, though the show’s intellectual property and dedicated fanbase could spark interest in streaming revival talks elsewhere. Quinto, a proven draw with credits ranging from “Star Trek” to Broadway, may find new opportunities quickly.

Fan Reactions and Legacy

Social media erupted with disappointment following the announcement. Fans praised the series for its representation of neurological differences and thoughtful storytelling in an era of formulaic procedurals. Hashtags like #SaveBrilliantMinds and #RenewBrilliantMinds briefly trended, with calls for Peacock to pick up a third season.

One recurring theme in viewer comments: the show’s educational value. Many shared how episodes prompted discussions about mental health, empathy in medicine and neurodiversity. While not a massive commercial hit, “Brilliant Minds” left an impression on those who found it.

Television executives note that passionate but small audiences increasingly struggle in the linear model. Streaming metrics, which NBC does not always disclose, may have played a role, but insufficient linear delivery sealed the fate.

What’s Next for the Cast and Network

Quinto and the ensemble have wrapped production. The summer burn-off will give loyal viewers closure as the final six episodes air. Whether those installments can generate buzz or streaming numbers remains to be seen.

For NBC, the focus shifts to developing replacements for the Monday 10 p.m. slot. Early indications point to new drama pilots emphasizing broader appeal or franchise extensions. The network will also lean on proven performers like “The Voice,” “Chicago” series and “Law & Order” while testing fresh concepts.

The cancellation of “Brilliant Minds” underscores ongoing industry turbulence. Broadcast networks grapple with declining overall viewership, rising production costs and competition from unlimited streaming libraries. Shows that once would have survived on modest numbers now face swift axes unless they deliver breakout demos or strong delayed viewing.

As summer episodes roll out, “Brilliant Minds” exits not with a ratings bang but with quiet appreciation from fans and critics who valued its ambition. In an era where data drives decisions, the series proved that critical heart and audience connection do not always translate to renewal in the competitive television landscape. NBC moves forward, hoping its next medical drama finds the elusive balance of quality and commercial success.